{"id":"https://openalex.org/W2787658258","doi":null,"title":"The role of GLP-1 receptor agonist as a potential treatment for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","display_name":"The role of GLP-1 receptor agonist as a potential treatment for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","alternate_titles":[],"publication_year":2017,"publication_date":"2017-01-01","ids":{"openalex":"https://openalex.org/W2787658258","mag":"2787658258"},"language":"en","primary_location":{"id":"pmh:oai:open.bu.edu:2144/26621","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/2144/26621","pdf_url":null,"source":{"id":"https://openalex.org/S4306402384","display_name":"OpenBU (Boston University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I111088046","host_organization_name":"Boston University","host_organization_lineage":["https://openalex.org/I111088046"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis/Dissertation"},"parent_works":[],"lineage":["https://openalex.org/W2787658258"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048554601","display_name":"Sara Behbahani","orcid":"https://orcid.org/0000-0001-9159-4745","observed_orcids":["https://orcid.org/0000-0001-9159-4745"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Sara Behbahani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5048554601"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-alcoholic-fatty-liver-disease","display_name":"non-alcoholic fatty liver disease","score":0.9240000247955322},{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":1.0},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9929999709129333},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9909999966621399},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":1.0},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.8759999871253967},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.5440000295639038},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9950000047683716},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.5550000071525574},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.8080000281333923},{"id":"https://openalex.org/keywords/obeticholic-acid","display_name":"obeticholic acid","score":0.7910000085830688},{"id":"https://openalex.org/keywords/farnesoid-x-receptor-agonist","display_name":"farnesoid X receptor agonist","score":0.8849999904632568},{"id":"https://openalex.org/keywords/vitamin-e","display_name":"vitamin E","score":0.7110000252723694},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.7149999737739563},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9520000219345093}],"concepts":[{"id":"https://openalex.org/C2779478299","wikidata":"https://www.wikidata.org/wiki/Q2335423","display_name":"Steatohepatitis","level":4,"score":0.8791369199752808},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.7975962162017822},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6504366397857666},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5759292840957642},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5528035163879395},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5355026721954346},{"id":"https://openalex.org/C2777575235","wikidata":"https://www.wikidata.org/wiki/Q558404","display_name":"Alcoholic liver disease","level":3,"score":0.531708300113678},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.4567573666572571},{"id":"https://openalex.org/C2993741276","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Alcoholic fatty liver","level":4,"score":0.4147881865501404},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.34949761629104614},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3472439646720886},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.29311949014663696},{"id":"https://openalex.org/C2777214474","wikidata":"https://www.wikidata.org/wiki/Q147778","display_name":"Cirrhosis","level":2,"score":0.05582857131958008}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:open.bu.edu:2144/26621","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/2144/26621","pdf_url":null,"source":{"id":"https://openalex.org/S4306402384","display_name":"OpenBU (Boston University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I111088046","host_organization_name":"Boston University","host_organization_lineage":["https://openalex.org/I111088046"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis/Dissertation"},{"id":"mag:2787658258","doi":null,"is_oa":false,"landing_page_url":"https://open.bu.edu/bitstream/2144/26621/5/Behbahani_bu_0017N_13233.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3080211465","https://openalex.org/W4317805724","https://openalex.org/W4387844971","https://openalex.org/W4316664733","https://openalex.org/W4378575756","https://openalex.org/W2253791229","https://openalex.org/W2902773974","https://openalex.org/W4392757320","https://openalex.org/W2903233854","https://openalex.org/W3164985374"],"abstract_inverted_index":{"Non-alcoholic":[0],"fatty":[1],"liver":[2,11,27,30,93,96,258,338],"disease":[3,225],"(NAFLD)":[4],"is":[5,76,122,205,209,323],"the":[6,14,20,72,77,92,100,115,126,139,165,194,198,216,221,224,227,234,242],"most":[7],"common":[8],"cause":[9,199],"of":[10,19,34,47,69,79,91,102,117,200,223,233,342,358],"dysfunction":[12],"in":[13,71,81,142,167,187,215,260,282,325,334],"western":[15],"world":[16],"and":[17,25,29,36,50,66,89,94,110,149,202,226,273,286,288,304,330],"one":[18],"main":[21],"contributors":[22],"to":[23,43,87,114,129,138,156,218,256,278,294,310,313,348],"cirrhosis":[24],"potentially":[26,335],"cancer":[28],"failure.":[31],"A":[32],"variety":[33],"behaviors":[35],"other":[37],"factors":[38,55],"can":[39,135],"predispose":[40],"certain":[41],"individuals":[42],"an":[44,350],"increased":[45],"risk":[46],"developing":[48],"NAFLD":[49,201,303],"non-alcoholic":[51,263],"steatohepatitis":[52],"(NASH).":[53],"These":[54],"include,":[56],"but":[57,169],"are":[58,185],"not":[59],"limited":[60],"to,":[61],"obesity,":[62,274],"insulin":[63],"resistance,":[64],"hyperglycemia,":[65],"high":[67],"levels":[68],"fat":[70,80],"blood.":[73],"The":[74],"result":[75],"accumulation":[78],"hepatocytes":[82],"that":[83,134,241,354],"over":[84],"time":[85],"leads":[86],"inflammation":[88],"scarring":[90],"ultimately":[95],"damage.":[97,339],"At":[98],"present,":[99],"mainstay":[101],"therapy":[103,133],"remains":[104],"weight":[105],"loss":[106],"through":[107],"dietary":[108],"modification":[109],"lifestyle":[111],"change.":[112],"Due":[113],"lack":[116],"specific":[118],"targeted":[119],"pharmacotherapies,":[120],"there":[121,208],"great":[123,191,280,332],"interest":[124],"from":[125],"scientific":[127],"community":[128],"find":[130],"a":[131,210,267,296,345],"potential":[132,228,297],"provide":[136,279,295],"benefit":[137,281,356],"many":[140],"patients":[141,261,301,359],"need.":[143],"Some":[144],"existing":[145],"medications,":[146],"including":[147],"pioliglitazones":[148],"angiotensin":[150],"receptor":[151,181,249],"antagonists,":[152],"may":[153,163],"be":[154,311],"repurposed":[155],"help":[157],"treat":[158],"this":[159,315],"condition.":[160],"Vitamin":[161],"E":[162],"improve":[164],"histology":[166],"NASH,":[168],"safety":[170],"issues":[171],"limit":[172],"its":[173],"use.":[174],"Other":[175],"drugs,":[176],"such":[177],"as":[178,197,247],"farnesoid":[179],"X":[180],"agonist,":[182],"obeticholic":[183],"acid,":[184],"also":[186,299],"clinical":[188,328,352],"trials":[189,329],"with":[190,262,302],"hope":[192,333],"for":[193,212,229,231,269,300],"future.":[195],"However,":[196,306],"thereby":[203],"NASH":[204],"poorly":[206],"understood,":[207],"need":[211,353],"further":[213,336],"research":[214,308],"field":[217],"better":[219],"understand":[220],"pathophysiology":[222],"pharmacotherapy":[230],"treatment":[232,298],"disease.":[235],"There":[236],"has,":[237],"however,":[238],"been":[239,254,276],"evidence":[240],"antidiabetic":[243],"drug":[244,268],"class":[245,341],"known":[246],"glucagon-like":[248],"agonists":[250],"(GLP-1":[251],"RAs)":[252],"has":[253,275],"shown":[255,277],"reduce":[257],"damage":[259],"steatohepatitis.":[264],"Liraglutide,":[265],"currently":[266,324],"type":[270,283],"2":[271,284,327],"diabetes":[272,285],"obesity":[287],"after":[289],"reviewing":[290],"multiple":[291],"studies,":[292],"seems":[293],"NASH.":[305],"more":[307,318],"needs":[309],"done":[312],"confirm":[314],"hypothesis.":[316],"Its":[317],"potent":[319],"version,":[320],"called":[321],"semaglutide,":[322],"phase":[326],"provides":[331,344],"reducing":[337],"This":[340],"drugs":[343],"huge":[346],"opportunity":[347],"address":[349],"unmet":[351],"could":[355],"millions":[357],"worldwide.":[360],"\\n":[361,362,363,364,365,366,367,368],"\\n.":[369]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2787658258","counts_by_year":[],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2018-02-23T00:00:00"}
